Structure and Inhibitor Binding Characterization of Oncogenic MLLT1 Mutants

Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent epigenetic reader domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, the structural basis...

Full description

Saved in:
Bibliographic Details
Published inACS chemical biology Vol. 16; no. 4; pp. 571 - 578
Main Authors Ni, Xiaomin, Londregan, Allyn T, Owen, Dafydd R, Knapp, Stefan, Chaikuad, Apirat
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 16.04.2021
Online AccessGet full text

Cover

Loading…
More Information
Summary:Dysfunction of YEATS-domain-containing MLLT1, an acetyl/acyl-lysine dependent epigenetic reader domain, has been implicated in the development of aggressive cancers. Mutations in the YEATS domain have been recently reported as a cause of MLLT1 aberrant reader function. However, the structural basis for the reported alterations in affinity for acetylated/acylated histone has remained elusive. Here, we report the crystal structures of both insertion and substitution mutants present in cancer, revealing significant conformational changes of the YEATS-domain loop 8. Structural comparison demonstrates that not only did such alteration alter the binding interface for acetylated/acylated histones, but the sequence alterations in the loop in T1 mutant may enable dimeric assembly consistent with inducing self-association behavior. Nevertheless, we show that also the MLLT1 mutants can be targeted by developed acetyllysine mimetic inhibitors with affinities similarly to wild-type. Our report provides a structural basis for the altered behaviors and a potential strategy for targeting oncogenic MLLT1 mutants.
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
ISSN:1554-8929
1554-8937
DOI:10.1021/acschembio.0c00960